Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tocilizumab biosimilar by Celltrion for Rheumatoid Arthritis: Likelihood of Approval
Tocilizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Rheumatoid Arthritis. According to GlobalData, Pre-Registration drugs...
Data Insights
Risk adjusted net present value: What is the current valuation of Celltrion's Tocilizumab biosimilar?
Tocilizumab biosimilar is a monoclonal antibody commercialized by Celltrion, with a leading Pre-Registration program in Rheumatoid Arthritis. According to Globaldata,...